Korea's drug safety ministry rolls out rare-disease films on KTX trains
The food and drug safety ministry has released 10 animated videos on psoriasis, phenylketonuria and neuroendocrine tumors, made with patient groups, for screening on KTX cabin monitors and online channels.

South Korea's food and drug safety ministry said Tuesday it has begun showing 10 educational videos on rare diseases on KTX cabin monitors and online channels, content produced with patient groups, including patients themselves, to explain conditions that many Koreans rarely encounter.
The videos cover three diseases — psoriasis, phenylketonuria and neuroendocrine tumors — and set out basic information on each, guidance on taking related medicines and precautions for daily life. The series is made up of four longer general and educational films and six short clips for platforms such as YouTube and Instagram, all animated around the ministry's "Ansim Family" characters.
Patients and their organizations helped choose which diseases needed explaining, then took part directly in drafting scripts, reviewing content and checking facts. The work was carried out with the Korea Alliance of Patients Organizations and the Korea Organization for Rare and Intractable Diseases, an umbrella of 98 groups.
The ministry, formally the Ministry of Food and Drug Safety, said it would distribute the videos through its own website, YouTube channel, blog and email newsletter, and also post them to the drug safety country site, a medical device information channel and a school health information center run by the education ministry. It plans to supply the films to the patient groups that took part and to show them on digital displays at government and private institutions and on monitors inside its own buildings.
The release extends a series the ministry has produced since 2024 on how to use medical products safely, with each year adding new conditions: type 1 diabetes and pulmonary arterial hypertension in 2024, then spina bifida, congenital heart disease and Parkinson's disease in 2025.
"We will continue to work with patient organizations and experts to reflect patients' voices in policy, education and publicity, and to keep providing information suited to the public's level," the ministry said.
What this article is based on
Every fact in this article can be checked against the primary documents below.
- Government식품의약품안전처 정부 보도자료· Ministry of Food and Drug Safety· accessed Nov. 18, 2026
- Government영상 구성· korea.kr· accessed Nov. 18, 2026
© New Era Korea Daily. All rights reserved.